Apogee Therapeutics, Inc. · NASDAQ:APGE

Dambkowski Carl sold 26,400 Apogee Therapeutics, Inc. shares (Form 4)

Traded Jun 22, 2026 · Filed Jun 24, 2026

On Jun 22, 2026, Dambkowski Carl (Chief Medical Officer) sold 26,400 Apogee Therapeutics, Inc. shares at US$132.60 for US$3.5M under a trading plan, leaving 179,248 shares. Filed Jun 24, 2026 (Form 4).

Sold
26,400 shares
Price
US$132.60
Value
US$3.5M
Holding after
179,248 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 22, 2026Common StockSale26,400US$132.60179,248Direct

Source

View original at SEC

Related